ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Return on equity
ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-153.5%FY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -153.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AAPG financial trends
AAPG RevenueAAPG Net incomeAAPG Net marginAAPG Gross profitAAPG Gross marginAAPG Operating incomeAAPG Operating marginAAPG Operating cash flowAAPG Free cash flowAAPG Capital expendituresAAPG Stock buybacksAAPG Dividends paidAAPG Total assetsAAPG Total liabilitiesAAPG Shareholders’ equityAAPG overview →